skinny.

Latest / In Focus by The Hindu

How are drug prices regulated in India? | In Focus podcast

In mid-December, a government department told the Kerala High Court that Ribociclib, a drug prescribed for a type of breast cancer, did not meet the conditions necessary to issue a compulsory licence. The drug is patented and therefore cannot be made by generic manufacturers but a compulsory licence, if issued by the government would permit a drug to be manufactured and made available at an affordable price. The case involved a woman, now deceased who said that she and her husband had a joint income of ₹74,400 a month, while the drug Ribociclib cost her ₹58,140, making it unaffordable. A…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.